Journal article icon

Journal article

Tuberculosis vaccines in clinical trials.

Abstract:

Effective prophylactic and/or therapeutic vaccination is a key strategy for controlling the global TB epidemic. The partial effectiveness of the existing TB vaccine, bacille Calmette-Guérin (BCG), suggests effective vaccination is possible and highlights the need for an improved vaccination strategy. Clinical trials are evaluating both modifications to the existing BCG immunization methods and also novel TB vaccines, designed to replace or boost BCG. Candidate vaccines in clinical development...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1586/erv.11.28

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Jenner Institute
Role:
Author
Journal:
Expert review of vaccines
Volume:
10
Issue:
5
Pages:
645-658
Publication date:
2011-05-05
DOI:
EISSN:
1744-8395
ISSN:
1476-0584
URN:
uuid:154adbcf-3852-49e5-af03-81e96e37797d
Source identifiers:
141763
Local pid:
pubs:141763

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP